ANEB
Anebulo Pharmaceuticals Inc
NASDAQ: ANEB · HEALTHCARE · BIOTECHNOLOGY
$0.43
-11.78% today
Updated 2026-04-29
Market cap
$22.43M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.18
Dividend yield
—
52W range
$0 – $3
Volume
0.0M
Anebulo Pharmaceuticals Inc (ANEB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | $3.03M | $21.65M | $15.58M | $11.67M | $4.07M | $12.15M |
| Cash & equivalents | $3.02M | $19.99M | $14.55M | $11.25M | $3.09M | $11.63M |
| Current assets | $3.03M | $21.65M | $15.58M | $11.67M | $3.51M | $11.96M |
| Total liabilities | $223865.00 | $241633.00 | $512531.00 | $1.07M | $260583.00 | $487688.00 |
| Current liabilities | $223865.00 | $241633.00 | $512531.00 | $1.07M | $260583.00 | $224175.00 |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $2.80M | $21.41M | $15.07M | $10.60M | $3.81M | $11.66M |
| Retained earnings | $-183137.00 | $-38.64M | $-45.47M | $-57.20M | $-65.40M | $-73.89M |
| Accounts receivable | $3500.00 | — | — | — | — | $73218.00 |
| Inventory | $-3.00 | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — |